The Role of Cardiac Magnetic Resonance Imaging in the Detection and Monitoring of Cardiotoxicity in Patients With Breast Cancer After Treatment: A Comprehensive Review Publisher Pubmed



Jafari F^{1, 2} ; Safaei AM² ; Hosseini L³ ; Asadian S⁴ ; Kamangar TM² ; Zadehbagheri F⁵ ; Rezaeian N⁴ Show Affiliations
Source: Heart Failure Reviews Published:2021

Abstract

The use of chemotherapy medicines for breast cancer (BC) has been associated with an increased risk of cardiotoxicity. In recent years, there have been growing interests regarding the application of cardiovascular magnetic resonance (CMR) imaging, a safe and noninvasive modality, with the potential to identify subtle morphological and functional changes in the myocardium. In this investigation, we aimed to review the performance of various CMR methods in diagnosing cardiotoxicity in BC, induced by chemotherapy or radiotherapy. For this purpose, we reviewed the literature available in PubMed, MEDLINE, Cochrane, Google Scholar, and Scopus databases. Our literature review showed that CMR is a valuable modality for identifying and predicting subclinical cardiotoxicity induced by chemotherapy. The novel T1, T2, and extracellular volume mapping techniques may provide critical information about cardiotoxicity, in addition to other CMR features such as functional and structural changes. However, further research is needed to verify the exact role of these methods in identifying cardiotoxicity and patient management. Since multiple studies have reported the improvement of left ventricular performance following the termination of chemotherapy regimens, CMR remains an essential imaging tool for the prediction of cardiotoxicity and, consequently, decreases the mortality rate of BC due to heart failure. © 2020, Springer Science+Business Media, LLC, part of Springer Nature.